Accessible Search Form

Skip left side navigation and go to content


Targeted Funding Opportunity Announcements (FOAs)

Submission date: various dates apply

The NHLBI is currently participating in the following targeted funding opportunities.

FOA Title


Receipt Dates

Stem Cell-Derived Blood Products for Therapeutic Use: Technology Improvement (R41, R43/R44)

Please email to request slides from the webinar on 1/8/15.

STTR: RFA- HL-15-029 external disclaimer
SBIR: RFA- HL-15-030 external disclaimer

February 20, 2015 (Phase I or SBIR Fast-Track)
February 20, 2016 (SBIR Phase I; Phase II; or Fast-Track only)
February 20, 2017 (SBIR Phase II only)

Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator- Directed Therapeutics (R41, R43/R44)

STTR: RFA- HL-15-026 external disclaimer
SBIR: RFA-HL-15-027 external disclaimer

February 9, 2015
November 9, 2015
November 9, 2016 (SBIR only)

Bioreactors for Reparative Medicine (R41/R42, R43/R44)

Please email to request slides from the webinar on 9/12/14.

SBIR: RFA-HL-15-008 external disclaimer
STTR: RFA-HL-15-004 external disclaimer
Direct to Phase II
(SBIR): RFA-HL-15-017 external disclaimer

October 10, 2014 (no Direct Phase II)
April 14, 2015 (no Direct Phase II)
October 14, 2015
April 14, 2016
October 14, 2016

Onsite Tools and Technologies for Heart, Lung, and Blood Clinical Research Point-of-Care (R41/R42, R43/R44)

SBIR: RFA-HL-14-011 external disclaimer
STTR: RFA-HL-14-017 external disclaimer

October 15, 2014
April 16, 2015 (SBIR only)
October 15, 2015
October 15, 2016 (STTR only)

Technologies To Assess Sleep Health Status in Populations (R43/R44)

SBIR: HL-14-013 external disclaimer

November 14, 2014 (Phase I and Phase II)
November 13, 2015 (Phase II only)

Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood and Sleep Technologies with Small Commercial Markets (R44)

Register for the informational webinar on May 6, 2015

SBIR: HL-14-012
More information

June 19, 2015

NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44)

Register for the informational webinar on May 6, 2015

SBIR: HL-16-009
More information

June 19, 2015; June 20, 2016; June 19, 2017

Developing a Point-of-Care Device for the Diagnosis of Sickle Cell Disease in Low Resource Settings SBIR (R43/ R44)

SBIR: HL-14-010

October 23, 2015 (Phase II only)

Developing Improved Assessments of Tissue Oxygenation (R44)

SBIR (Phase II only):

November 16, 2015

New Technologies for Viral Hepatitis (SBIR/STTR)

SBIR: PA-15-077

STTR: PA-15-076

Standard dates
Through January 8, 2018

Development of Highly Innovative Tools and Technology for Analysis of Single Cells (R43/R44)

SBIR: PA-13-140

Standard dates
Through January 8, 2016

Safe and Effective Instruments and Devices for Use in Neonatal and Pediatric Care Settings (R41/R42, R43/R44)

SBIR: PAR-13-090
STTR: PAR-13-091

Standard dates
Through May 8, 2016

If your research doesn't fit one of the targeted FOAs above, you can submit an investigator-initiated application using the Omnibus Grant Solicitation or find another NIH Institute or Center that is more closely aligned with your research interests. You can view the SBIR/STTR FOAs for all of NIH here or search the NIH Guide for funding opportunities here.

Last Updated April 2015

Twitter iconTwitter external disclaimer Facebook iconFacebook external disclaimer YouTube iconYouTube external disclaimer Google+ iconGoogle+ external disclaimer